Welltower is the largest healthcare REIT (real estate investment trust), focused on senior housing, wellness housing, and outpatient medical properties. Its stock is widely covered: recent reporting from S&P Global lists 22 analysts with an average target near $261 and a "Buy" consensus, while MarketBeat's 20-analyst sample averages about $256.
For this analysis, twelve individually attributed, current targets were collected: Wells Fargo ($268, Oct. 19), UBS ($269, Oct. 13), Barclays ($246, Oct. 13), Jefferies ($260, Oct. 12), BMO Capital ($265, Oct. 2), Morgan Stanley ($215, Aug. 4), Bank of America ($292, Aug. 3), KeyBanc ($275, Aug. 4), Cantor Fitzgerald ($260, July 31), Citi ($275, July 31), RBC Capital ($260, July 31), and Evercore ISI ($260, July 30). The range is $215 to $292, and the overall average is roughly $262.
Because that rounded mean of $260 sits less than 10% above the current price, the central target is instead the average of the eleven targets above the current price, about $266, rounded to $270. Bullish analysts emphasize accelerating same-store revenue as occupancy crosses key thresholds, while more cautious voices such as Barclays (which cut its target to $246) flag valuation and near-term execution.
Shares closed near $237.32 in late October 2026, within a 52-week range of roughly $174.91 to $255.20. The stock set its recent high near $255 in July before consolidating, so the $270 target sits above that prior peak and implies a substantial move of about 14%.
Welltower's path would likely depend on continued occupancy gains, senior-housing rent growth, and a healthy pace of acquisitions, alongside a supportive interest-rate backdrop. As a REIT, it is typically evaluated on FFO (funds from operations) rather than earnings per share, which helps explain a headline P/E (price-to-earnings) ratio that appears elevated.
The core argument is demographic and operational. An aging population and limited new senior-housing construction support demand, and management has guided same-store NOI (net operating income) growth of roughly 18% to 21.5% for 2026 as occupancy climbs and pricing power improves. Welltower has also been deploying capital aggressively, targeting billions of dollars in incremental acquisitions that management expects to fold into its operating platform over time. A lower-interest-rate environment and continued analyst revisions higher would reinforce the bullish case.
Valuation is the most frequently cited obstacle. Even with strong growth, the stock trades at a premium by several metrics, and at least one data provider places its intrinsic-value estimate below $205. Higher borrowing costs would raise acquisition financing expenses and pressure the multiple investors are willing to pay. Labor availability and immigration policy affect caregiver staffing, and newly acquired properties take time to reach full occupancy and margin potential. Any slowdown in same-store NOI growth or a guidance cut would likely weigh on the shares.
Technically, the prior high near $255 acts as an initial resistance zone, with the $270 target above it and the $292 area marking the most aggressive analyst objective. On the downside, commentary has cited support near $223, with the $200–$215 band representing a deeper level associated with the lowest current targets and round-number psychology.
Analyst price targets generally reflect a research horizon of about 12 months, though individual assumptions vary. Investors should watch quarterly results for occupancy, same-store NOI growth, and acquisition activity; any analyst target revisions; interest-rate decisions; and labor-cost trends. Because these targets are estimates rather than forecasts of a specific timeline, no single date should be treated as a guarantee.
AI Daily Buy/Sell Signals from Tickeron use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-driven analysis. Traders can use these signals to discover opportunities, monitor existing positions, and spot changing trends more efficiently than manual screening allows. For investors tracking Welltower's progress toward its target, this type of automated monitoring can help flag momentum shifts as they develop.
The $270 target reflects the average of eleven analyst price targets above Welltower's current price, requiring a roughly 14% gain. The bull case rests on durable senior-housing demand, improving pricing power, and an active acquisition strategy, while the bear case centers on a premium valuation, rate sensitivity, and execution risk. With a wide analyst range from $215 to $292, expectations are far from uniform. Whether Welltower approaches $270 will depend chiefly on whether its operational momentum and acquisition integration continue to justify its current multiple.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, WELL has been closely correlated with VTR. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if WELL jumps, then VTR could also see price increases.
| Ticker / NAME | Correlation To WELL | 1D Price Change % | ||
|---|---|---|---|---|
| WELL | 100% | -0.03% | ||
| VTR - WELL | 80% Closely correlated | -0.22% | ||
| AHR - WELL | 73% Closely correlated | -0.71% | ||
| OHI - WELL | 67% Closely correlated | -0.15% | ||
| CTRE - WELL | 66% Closely correlated | N/A | ||
| LTC - WELL | 66% Loosely correlated | +0.97% | ||
More | ||||
| Ticker / NAME | Correlation To WELL | 1D Price Change % |
|---|---|---|
| WELL | 100% | -0.03% |
| WELL (6 stocks) | 96% Closely correlated | +1.04% |
| Publishing: Books/Magazines (18 stocks) | 91% Closely correlated | +0.43% |
| Consumer Services (219 stocks) | 18% Poorly correlated | -0.29% |